Geoffrey Kuppens

Dr. Geoffrey Kuppens

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BLBernard Leenstra
Bernard Leenstra
RKRobert de Kleijn
Robert de Kleijn
GKGeoffrey Kuppens
Geoffrey Kuppens
BVBart Arnoldus Nicolaas Verhoeven
Bart Arnoldus Nicolaas Verhoeven
JHJan Willem Hinnen
Jan Willem Hinnen
Gert Jan de BorstGert Jan de Borst
Gert Jan de Borst
Currently, transcutaneous oxygen tension measurement (TCpO2) is the most favorable non-invasive test for diabetic foot ulcer (DFU) healing prognosis. Photo-optical TCpO2 is novel, less time-consuming and more practical in use compared to regular electro-chemical TCpO2. We prospectively investigated the clinical value of photo-optical TCpO2 to predict DFU healing. Patients with suspected DFU undergoing conservative treatment underwent an ankle pressure, toe-pressure and photo-optical TCpO2 test. The primary endpoint was DFU wound healing at 12 months. Based on their clinical outcome, patients were divided into a DFU healing and DFU non-healing group. Healing was defined as fully healed ulcers and non-healing as ulcers that deteriorated under conservative treatment or that required surgical amputation. Differences between groups were analyzed and an optimal TCpO2 cut-off value was determined. In total, 103 patients were included, of which 68 patients (66%) were classified as DFU healing. The remaining 35 patients (34%) had deteriorated ulcers, of which 29 (83%) eventually required surgical amputation. An optimal TCpO2 cut-off value of 43 mmHg provided a sensitivity, specificity and odds ratio of 0.78, 0.56 and 4.4, respectively. Photo-optical TCpO2 is an adequate alternative tool to validate the vascular status of the lower extremity indicating healing prognosis in patients with DFU. Therefore, we recommend that photo-optical TCpO2 can be safely coapplied in clinical practice to assist in DFU treatment strategy.

15 July 2024 in Haemophilia
Verified
Journal Article
Open access
GKGeoffrey Kuppens
Geoffrey Kuppens
KFKathelijn Fischer
Kathelijn Fischer
KGKarin P. M. van Galen
Karin P. M. van Galen
EBEduard J. van Beers
Eduard J. van Beers
PVPaul R. Van der Valk
Paul R. Van der Valk
RSRoger E. G. Schutgens
Roger E. G. Schutgens
Introduction: Patients with von Willebrand disease (VWD) require administration of von Willebrand factor (VWF) concentrates peri‐operatively. Concerns about FVIII accumulation after repetitive injections of a 1:1 ratio VWF/FVIII clotting factor concentrate (CFC) led this study to explore the recovery and FVIII accumulation over time.Methods: This monocentre study examined patients with VWD receiving perioperative 1:1 ratio CFC infusions. CFC dosing was based on body weight and endogenous VWF/FVIII activity. FVIII and VWF activity was monitored at T0 (baseline), T1 (15 min postinfusion), and trough levels at T2‐T6 (24‐120 h).Results: We included 125 patients, undergoing 125 procedures (63 major surgeries, 62 minor), with a median of two CFC infusions (IQR 1–3). With a mean administered dose of 35.7 IU/kg CFC, recovery rates of FVIII and VWF were 2.6 IU/dL per IU/kg and 2.4 IU/dL per IU/kg, respectively. Mean FVIII levels at T0 were 62 (SD 51.9), T1: 164 (SD 80.4), T2: 155 (SD 62.8), T3: 162 (SD 59.8), T4: 124 (SD 78.4), and T5: 120 (SD 65.3) IU/dL. Mean VWF activity levels at T0 were 29 (SD 25.0), T1: 133 (SD 43.7), T2: 92 (SD 37.2), and T3: 86 (SD 37.5) IU/dL. Subgroup analysis in 47 patients with more than three infusions, showed no accumulation of mean FVIII levels.Conclusion: This perioperative study demonstrated excellent FVIII and VWF recovery of a 1:1 ratio VWF product in patients with VWD. Stable FVIII and VWF activity levels were observed after repeated infusions, without accumulation. Most major surgeries required only three CFC infusions.

1 November 2021 in Annals of Vascular Surgery
Verified
Journal Article
Open access
BLBernard Leenstra
Bernard Leenstra
GKGeoffrey Kuppens
Geoffrey Kuppens
ABAnnette van Bergen
Annette van Bergen
RKRobert de Kleijn
Robert de Kleijn
Gert Jan de BorstGert Jan de Borst
Gert Jan de Borst
BVBart Verhoeven
Bart Verhoeven
Photo-optical TCpO2 (pTCpO2) has been proposed as a new method to determine the partial oxygen pressure of the lower extremity in patients with peripheral arterial disease. It is aimed to determine the level of agreement between pTCpO2 and the traditional electro-chemical transcutaneous oxygen tension measurement (eTCpO2). Eighteen patients with intermittent claudication underwent simultaneous ankle-brachial index measurement, toe-pressure, pTCpO2 and eTCpO2 tests. Oxygen tension levels were measured on anterior chest and calf prior in rest (T0), during induced ischemia (T1) and after blood flow restoration (T2). TCpO2 agreement was assessed according to the principles of Bland and Altman. Absolute average TCpO2 values differed between eTCpO2 and pTCpO2 for calf in T2 (38,1 mmHg (σ 14,4) vs. 49,8 (σ 22.3) with P = 0.35). The Bland-Altman plots demonstrated eTCpO2 and pTCpO2 bias of 3,7 mmHg (σ 18,8), 11,6 mmHg (σ 17,6) and 6,7 mmHg (σ 23,5) for T0, T1 and T2 for the calf. pTCpO2 is in agreement with eTCpO2 in measuring pO2 levels of the lower extremity in rest and during induced ischemia in patients with vascular claudication. The large variability between eTCpO2 and pTCpO2 should be accounted for, while pTCpO2 values have a tendency to demonstrate higher values in comparison to eTCpO2.

31 March 2026 in British Journal of Haematology
Verified
Journal Article
Open access
JWJonathan R. A. de Wilde
Jonathan R. A. de Wilde
GKGeoffrey Kuppens
Geoffrey Kuppens
MBMaryse E. Boesveld
Maryse E. Boesveld
AVAnnelies van Vuren
Annelies van Vuren
WSWouter van Solinge
Wouter van Solinge
RWRichard van Wijk
Richard van Wijk
Summary: Hereditary spherocytosis (HS) is a hereditary haemolytic anaemia, caused by pathogenic variants in genes encoding red blood cell membrane proteins. Osmotic gradient ektacytometry evaluates red cell deformability and hydration and is increasingly used in the diagnosis of HS. We retrospectively evaluated laboratory data from 233 HS patients focusing on osmotic gradient ektacytometry parameters, including two novel parameters, O min ‐width and O max ‐width. We found that the maximum elongation index (EI max ), representing the maximum deformability, was decreased in SPTB relative to SLC4A1 and SPTA1 (0.509 vs. 0.557 and 0.564, both p < 0.01). Hydration was most affected in SLC4A1 , with the lowest median O hyper (416 mOsm/kg). The novel parameters also showed differences: O min ‐width was higher in SPTB and ANK1 compared to SLC4A1 and SPTA1 ( p < 0.05). O max ‐width was lowest in SLC4A1 (92 mOsm/kg). We found that non‐missense variants, opposed to missense variants, were associated with decreased deformability in SPTB and ANK1 subgroups as well as with decreased hydration in the ANK1 subgroup specifically (O hyper missense 472 mOsm/kg vs. non‐missense 436 mOsm/kg). Lastly, when classifying disease severity based on reticulocyte production index, we found that O min , EI max , area under the curve (AUC), O min ‐width and O max ‐width differed between mild and moderate patients (all p < 0.05). Our findings suggest that osmotic gradient ektacytometry provides additional information on HS pathophysiology and clinical severity.

10 July 2026 in Blood Red Cells & Iron
Verified
Journal Article
Open access
GKGeoffrey Kuppens
Geoffrey Kuppens
AVAnnelies van Vuren
Annelies van Vuren
SSStéphanie van Straaten
Stéphanie van Straaten
RWRichard van Wijk
Richard van Wijk
APArjen M. Punt
Arjen M. Punt
MBMarije Bartels
Marije Bartels